Filtered By:
Condition: Diabetes Type 2
Management: Healthcare Costs

This page shows you your search results in order of date.

Order by Relevance | Date

Total 22 results found since Jan 2013.

Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022 –2031
ConclusionsCVD in people with type 2 diabetes will substantially impact the Australian healthcare system and society over the next decade. Future work to investigate different strategies to optimize the control of risk factors for the prevention and treatment of CVD in type 2 diabetes in Australia is warranted.
Source: PharmacoEconomics - March 21, 2023 Category: Health Management Source Type: research

Obesity and kidney transplantation
Curr Opin Organ Transplant. 2023 Feb 1. doi: 10.1097/MOT.0000000000001050. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Obesity has reached epidemic proportions in the United States. It is a risk factor for developing, among others, heart disease, stroke, type 2 diabetes, and chronic kidney disease (CKD), and thus a major public health concern and driver of healthcare costs. Although the prevalence of obesity in the CKD/end-stage kidney disease population is increasing, many obese patients are excluded from the benefit of kidney transplant based on their BMI alone. For this reason, we sought to review the experience th...
Source: Current Opinion in Organ Transplantation - February 8, 2023 Category: Transplant Surgery Authors: Jae-Hyung Chang Vladimir Mushailov Sumit Mohan Source Type: research

Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease
Conclusion: Having stroke, MI, or PAD was associated with increases in HCRU and costs in patients with T2DM. Although PAD was associated with smaller per patient increases in total healthcare costs than patients with T2DM + stroke/MI, the higher frequency of incident PAD may make it more costly than MI or stroke in a large population of patients with T2DM.PMID:36134459 | DOI:10.1080/03007995.2022.2125259
Source: Current Medical Research and Opinion - September 22, 2022 Category: Research Authors: Aaron King Jigar Rajpura Yuanjie Liang Yurek Paprocki Chioma Uzoigwe Source Type: research

Only 7% of Americans Have Optimal Heart Health, Study Says
Peak heart health is rare in the U.S.—and increasingly uncommon. A new study published in the Journal of the American College of Cardiology finds that fewer than 7% of all American adults have optimal health across five major areas related to heart and metabolic health: weight, blood sugar, blood pressure, cholesterol, and cardiovascular disease status. And the problem is getting worse. These five categories were adapted from the American Heart Association’s definition of ideal cardiovascular and metabolic health. The study, which analyzed National Health and Nutrition Examination Survey data from more than 55,...
Source: TIME: Health - July 5, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized healthscienceclimate Public Health Source Type: news

Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people
Basel, 28 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced a series of five new intended uses for two key cardiac biomarkers using the Elecsys ® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers³ have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks⁴ (cTnT-hs) and bett er manage heart failure⁵ (NT-proBNP). Roche ' s introduction of five new intended uses for these existing, globally accepted diagnostic solutions means more people could benef...
Source: Roche Media News - April 28, 2021 Category: Pharmaceuticals Source Type: news

Clinical Outcomes and Healthcare Resource Utilization in a Real-World Population Reflecting the DAPA-CKD Trial Participants
ConclusionThe significant adverse renal and cardiovascular outcomes observed, particularly in the DAPA-CKD-like cohort, represent a substantial burden resulting in increased mortality, HCRU and costs, demonstrating the need for additional treatment options.
Source: Advances in Therapy - January 20, 2021 Category: Drugs & Pharmacology Source Type: research

Assessing Risk of Future Cardiovascular Events, Healthcare Resource Utilization and Costs in Patients with Type 2 Diabetes, Prior Cardiovascular Disease and Both.
Conclusion: In this large and geographically broad U.S based cohort, CV risk for T2DM patients was elevated, as was the risk for patients with prior CV events, while patients with T2DM + prior CV events had the highest risk of future CV events. The substantial clinical and economic burden of CV and HF in patients with both T2DM and prior CV events suggest a need for an integrated treatment and targeted intervention across both conditions. PMID: 33023310 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - October 9, 2020 Category: Research Tags: Curr Med Res Opin Source Type: research

Estimation and Prediction of Avoidable Health Care Costs of Cardiovascular Diseases and Type 2 Diabetes Through Adequate Dairy Food Consumption: A Systematic Review and Micro Simulation Modeling Study.
CONCLUSION: Our analysis demonstrated that increasing dairy foods consumption to recommended levels would be associated with reductions in healthcare costs. Further randomized trial studies are required to investigate the effect of dairy foods intake on cost of CVD and T2DM in the population. PMID: 29738265 [PubMed - in process]
Source: Archives of Iranian Medicine - May 1, 2018 Category: Middle East Health Authors: Javanbakht M, Jamshidi AR, Baradaran HR, Mohammadi Z, Mashayekhi A, Shokraneh F, Rezai Hamami M, Yazdani Bakhsh R, Shabaninejad H, Delavari S, Tehrani A Tags: Arch Iran Med Source Type: research

Declines In Dementia: Of Hearts And Minds
In this season when we are meant to be thankful, but when so many of us have had so many reasons to be otherwise, we have received a timely, welcome bit of universally good news. Rates of dementia in the United States appear to be declining. This news reaches us courtesy of a study published recently in JAMA Internal Medicine. The investigators used standard, validated measures of cognitive function and dementia in two groups of more than 10,000 people in the U.S. with an average age of roughly 75 in the year 2000, and again in 2012. The overall rate of dementia declined over that span from 11.6% to 8.8%. Taking ...
Source: Science - The Huffington Post - November 27, 2016 Category: Science Source Type: news